Wealth Enhancement Advisory Services
NAGE

Wealth Enhancement Advisory Services’s Niagen Bioscience NAGE Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2K Sell
13,338
-4,522
-25% -$18.4K ﹤0.01% 3935
2026
Q1 		$78.2K Buy
+17,860
New +$96.4K ﹤0.01% 3367
2025
Q4 		– Sell
-13,470
Closed -$96.7K – 3831
2025
Q3 		$96.7K Buy
13,470
+63
+0.5% +$636 ﹤0.01% 3341
2025
Q2 		$170K Buy
+13,407
New +$132K ﹤0.01% 3028

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wealth Enhancement Advisory Services's NAGE Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Niagen Bioscience (NAGE) stake by 25% in Q2 2026, selling an estimated $18.4K and leaving 13,338 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3935.

Wealth Enhancement Advisory Services first reported a position in NAGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $170K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Wealth Enhancement Advisory Services held 13,338 shares of Niagen Bioscience worth $45.2K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 4,522 Niagen Bioscience shares in Q2 2026, an estimated $18.4K.
  • Niagen Bioscience made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3935 holding.
  • Wealth Enhancement Advisory Services first reported a position in Niagen Bioscience in Q2 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Niagen Bioscience position peaked at $170K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.